No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IMMP Immutep
- 2.600
- -0.090-3.35%
Close May 1 16:00 ET
- 2.800
- +0.200+7.69%
Post 19:59 ET
309.10MMarket Cap-10236P/E (TTM)
2.660High2.570Low212.20KVolume2.660Open2.690Pre Close554.61KTurnover0.20%Turnover RatioLossP/E (Static)118.88MShares3.90052wk High4.09P/B274.39MFloat Cap1.50052wk Low--Dividend TTM105.53MShs Float7.950Historical High--Div YieldTTM3.35%Amplitude0.530Historical Low2.613Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Immutep's Innovative Cancer Therapy Shows Promise
Immutep Started at Buy by Canaccord Genuity >IMM.AU
Immutep Started at Buy by Canaccord Genuity >IMM.AU
Immutep Shares Upbeat Clinical Trials Update
Canaccord Starts Immutep at Buy, Price Target Is AU$1.00
09:02 PM EDT, 04/29/2024 (MT Newswires) -- Canaccord Starts Immutep at Buy, Price Target is AU$1.00 Price (AUD): $0.45, Change: $, Percent Change: %
Immutep Reported Cash, Cash Equivalent Balance Of $95.4M As Of March 31, 2024, Giving It Expected Cash Reach Into Early CY2026
Immutep Reported Cash, Cash Equivalent Balance Of $95.4M As Of March 31, 2024, Giving It Expected Cash Reach Into Early CY2026
Immutep Announces Encouraging Clinical Results
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg